Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
26.55
-0.48 (-1.78%)
Feb 11, 2026, 4:00 PM EST
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 2.82 billion as of February 13, 2026. Its market cap has increased by 51.16% in one year.
Market Cap
2.82B
Enterprise Value
2.03B
Revenue
196.76M
Ranking
n/a
PE Ratio
61.86
Stock Price
26.55
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 2.82B, a decrease of -52.93%. That is a compound annual growth rate of -17.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.82B | 19.57% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Hile Bio-Technology | 3.13B |
| Suzhou Fushilai Pharmaceutical | 3.09B |
| Novoprotein Scientific | 3.05B |
| Shanghai Universal Biotech | 2.86B |
| Landfar Bio-medicine | 2.84B |
| Shandong Sito Bio-technology | 2.82B |
| Jilin Jian Yisheng Pharmaceutical | 2.75B |
| Jiangsu CoWin Biotech | 2.71B |